Explore more publications!

Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on February 27, 2026

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
Nordic Naturals and Kate Turner Discuss Why More Than 80% of Americans Are Falling Short on Omega-3s with YourUpdateTV
OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Answering the Call: Unity Reed High School Students Train for Lifesaving Careers in Public Safety
Publication relating to transparency notifications
Publication relative à des notifications de transparence
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
Aardvark Therapeutics Announces Voluntary Pause of Phase 3 HERO Trial in Prader-Willi Syndrome
5 Trends in Heart Health Among Younger Adults: Why Your CoQ10 Level Matters
NurExone to Showcase Its Regenerative Medicine Platform at NANO.IL.2026 and Advanced Therapies Congress in March 2026 and Provides Corporate Update
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
Arcutis Management to Present at TD Cowen’s 46th Annual Health Care Conference
Excellergy Presents New Data at 2026 AAAAI Annual Meeting Demonstrating Rapid and Sustained Allergic Effector Cell Control and Announces First Subjects Dosed in Phase 1 DISARM Trial
A Symbol of Crisis: As Colorectal Cancer Deaths Rise, Fight CRC Installs United in Blue on the National Mall
LeMaitre to Participate at Upcoming Investor Conferences in March
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at…
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
AshtonManual.org Launches as the Definitive Resource for Safe, Evidence-Based Benzodiazepine Tapering
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions